iX Biopharma Ltd. (SGX:42C)
0.4350
-0.0250 (-5.43%)
At close: Nov 20, 2026
| Market Cap | 475.59M +301.2% |
| Revenue (ttm) | 7.96M +6.2% |
| Net Income | -10.76M |
| EPS | -0.01 |
| Shares Out | 1.09B |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 8,964,800 |
| Open | 0.4500 |
| Previous Close | 0.4600 |
| Day's Range | 0.4250 - 0.4500 |
| 52-Week Range | 0.1100 - 0.6250 |
| Beta | 0.99 |
| Analysts | Strong Buy |
| Price Target | 1.09 (+149.43%) |
| Est. Earnings | Feb 5, 2027 |